"Sulfonylurea Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D013453
|
| MeSH Number(s) |
D02.886.590.795 D02.948.828
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sulfonylurea Compounds".
Below are MeSH descriptors whose meaning is more specific than "Sulfonylurea Compounds".
This graph shows the total number of publications written about "Sulfonylurea Compounds" by people in this website by year, and whether "Sulfonylurea Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sulfonylurea Compounds" by people in Profiles.
-
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. Diabetes Care. 2020 05; 43(5):940-947.
-
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2019 11; 42(11):2098-2107.
-
Body Weight Considerations in the Management of Type 2 Diabetes. Adv Ther. 2019 01; 36(1):44-58.
-
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes. Metabolism. 2018 08; 85:32-37.
-
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol. 2014; 127(6):825-43.
-
Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial. J Diabetes Complications. 2013 Nov-Dec; 27(6):627-32.
-
Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2012 Jan; 14(1):40-6.
-
Modulation of pantothenate kinase 3 activity by small molecules that interact with the substrate/allosteric regulatory domain. Chem Biol. 2010 Aug 27; 17(8):892-902.
-
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009 Jan 08; 360(2):129-39.
-
Pioglitazone hydrochloride/glimepiride. Drugs Today (Barc). 2007 Jul; 43(7):487-97.